Boris Becker's ex-wife Lilly has won the German version of I'm A Celebrity... Get Me Out Of Here! after stealing the hearts of the nation. The former Wimbledon tennis star, 57, has endured a ...

The Dutch model, 48, who is also the ex wife of Boris Becker, rocked a fedora hat and kept it minimal in an all-black ensemble with beige cardigan. Lilly looked radiant as she stopped to pose with ...

Eli Lilly and Co. reported that its FDA-approved weight-loss drug Zepbound (tirzepatide) outperformed Novo Nordisk A/S’s Wegovy (semaglutide) in the phase IIIb Surmount-5 trial.

the stars had to give up luxury items, some of which are there to provide emotional support, in Tuesday's episode. Hunger is also gnawing at them. Sam is to blame. Lilly is at her limit.

The reason: Sam Dylan has dropped out of all the jungle trials so far. Lilly Becker doesn't like this at all, even though she has already been through a lot in her life. With her ex, for example.

Patrick Mahomes says his faith is "part of everything I do" The NFL star, Patrick Mahomes is biracial since he was born to a Caucasian mother, Randi Martin while his father, the former MLB star ...

Lilly on Thursday reported fourth-quarter revenue of $13.53 billion, a steep 45% increase over the sum the Indianapolis-based drugmaker generated during the same period in 2023.

Getty Images Pharmaceutical company Eli Lilly is expected to report fourth-quarter earnings before the bell Thursday. Analysts tracking the company see increased sales and profit for Eli Lilly in ...

Police forces and courts are collecting less data on the ethnicity of criminals than at any time in the past 15 years amid fears of being called racist, figures have shown. Senior Tory MPs ...

As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company has taken the GLP-1 supply chain too far. Eli Lilly has faced constant cries ...

Eli Lilly's stock price finished Jan. 16 down 21% from a peak it set last September. The sales trajectory of Mounjaro and Zepbound tapered off in the second half of 2024. An oral weight-loss ...